Publication | Open Access

Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes

Surgical OncologyOncologyBreast OncologyPathologyOperable Breast CarcinomaBreast CancerPrimary ChemotherapyCancer TreatmentRadiation OncologyMedicineCancer ChemotherapyLong-term Outcomes